Everolimus in Refractory Testicular Germ Cell Cancer
Clinical trial NCT01466231 · COMPLETED
Trial details
- NCT number
- NCT01466231
- Sponsor
- National Cancer Institute, Slovakia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2015-06-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.